Two Sigma Securities’s PDL BioPharma, Inc. PDLI Stock Holding History

Two Sigma Securities’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,280	Closed	-$40K	–	2669
2019 Q4	$40K	Buy	+12,280	New	+$35.6K	﹤0.01%	2241
2019 Q3	–	Sell	-23,873	Closed	-$75K	–	2666
2019 Q2	$75K	Buy	23,873 +11,488	+93%	+$37.3K	﹤0.01%	1871
2019 Q1	$46K	Sell	12,385 -8,640	-41%	-$29.2K	﹤0.01%	1621
2018 Q4	$61K	Buy	+21,025	New	+$57.8K	﹤0.01%	1918
2018 Q3	–	Sell	-12,985	Closed	-$30K	–	3244
2018 Q2	$30K	Sell	12,985 -9,213	-42%	-$25.7K	﹤0.01%	2543
2018 Q1	$65K	Sell	22,198 -3,829	-15%	-$10.5K	﹤0.01%	2480
2017 Q4	$71K	Buy	+26,027	New	+$79.9K	﹤0.01%	1493
2017 Q3	–	Sell	-16,325	Closed	-$40K	–	1393
2017 Q2	$40K	Sell	16,325 -49,092	-75%	-$113K	0.01%	734
2017 Q1	$148K	Buy	+65,417	New	+$145K	0.03%	712
2016 Q3	–	Sell	-36,084	Closed	-$113K	–	888
2016 Q2	$113K	Buy	+36,084	New	+$120K	0.06%	311

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Securities's PDLI Position: Q1 2020 in Review

Two Sigma Securities sold out of PDL BioPharma, Inc. (PDLI) in Q1 2020, closing a stake of 12,280 shares — an estimated $40K sold.

Two Sigma Securities first reported a position in PDLI in Q2 2016 and held it in 10 quarters. The position peaked at $148K in Q1 2017. 132 funds tracked by Wall St. Rank hold PDLI as of Q1 2020.

Two Sigma Securities reported no remaining PDL BioPharma, Inc. position as of Q1 2020 after selling out during the quarter.
Two Sigma Securities sold 12,280 PDL BioPharma, Inc. shares in Q1 2020, an estimated $40K.
Two Sigma Securities first reported a position in PDL BioPharma, Inc. in Q2 2016 and held it in 10 quarters.
Two Sigma Securities's PDL BioPharma, Inc. position peaked at $148K in Q1 2017.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2020.

Based on Two Sigma Securities's 13F filing for Q1 2020, filed 15 May 2020.